Licorice Root (Glycyrrhiza glabra and Related Species)
1. Identity: Botanical Names, Natural Source, and Common Forms
Botanical and Chemical Identity
Licorice root belongs to Glycyrrhiza glabra Linn., a member of the Fabaceae (legume) family that has been recognized since ancient times for its ethnopharmacological values. The name derives directly from the plant's defining characteristic: the word liquorice essentially derives from Old Greek glykyrrhiza, where glykys means "sweet" and rhiza means "root."
While Glycyrrhiza glabra is the primary commercial species, two additional species — Glycyrrhiza uralensis (Chinese licorice) and Glycyrrhiza inflata — are also used medicinally and are recognized in pharmacopoeial standards. The concentration of glycyrrhizin varies from species to species, and the commercially used G. glabra, G. inflata, and G. uralensis species contain up to 2–25% (dry weight) of glycyrrhizin. Licorice is also spelled "liquorice" and is known as "Glycyrrhizae Radix et Rhizoma" (Chinese: 甘草, gan cao) in the Chinese Pharmacopoeia.
Licorice has several names across languages, including sweetwood, licorice, liquorice radix, réglisse (French), Lakritzeholz (German), Gan Cao (Chinese), Meyan or Beyan (Turkish), and Solodka (Russian).
Plant Description
Licorice is a perennial plant growing about 1.5 m high. The wrinkled and woody rootstock is brown on the outside and yellow on the inside. The leaves are unequally branched in four to seven pairs, and the flowers are pale blue, violet, yellowish white, or purplish in color, arising from the axils of the leaves in racemes or spikes, followed by pods.
Common Preparations and Dosage Forms
The root is harvested from three- to five-year-old plants and is available in a wide range of preparations. Dosage forms include extractum (extract), tablets, capsules, injections, granules, and oral solutions. Two fundamentally distinct product categories exist in modern supplement use: regular licorice (containing glycyrrhizin) and deglycyrrhizinated licorice (DGL, with glycyrrhizin removed). To prevent the adverse mineralocorticoid effects of glycyrrhizin, manufacturers have found a way to remove it from licorice, producing the product known as deglycyrrhizinated licorice (DGL). Industrial uses of licorice include a sweetener in cigarettes, chewing tobacco, chocolate candy, smoking mixes, and chewing gum. In cosmetology, licorice is used as a depigmenting agent. Health products containing glycyrrhizinic acid include licorice tea, flavored diet gum, cough mixtures, throat pearls, and herbal cough mixtures.
2. Traditional and Historical Use
Ancient Civilizations
Licorice roots have been used worldwide as a medicine and flavor in industry for over 4,000 years. Medicinal uses of licorice are recorded in texts such as the Assyrian Herbal (2000 BC) and the Ebers Papyrus (1600 BC). Licorice root has a long history of use, going back to ancient Assyrian, Egyptian, Greek, Arab, Chinese, Tibetan, and Indian cultures. It was used in traditional medicine practices for coughing, asthma, and wound healing, as well as for diseases of the lungs, liver, and arteries.
Egyptians and Assyrians used licorice as a sweet liquid beverage, while in the battlefields and the desert, soldiers and travelers drank it to quench their thirst. The early Egyptians and Assyrians are known to have cultivated the "sweet root," which was later imported to China, where it has been used for centuries under the name "Gan Cao." It has also been described by ancient Greeks, including Hippocrates and Theophrastus, as well as by Romans.
Licorice was a prescriptive agent of Hippocrates in the treatment of asthma, dry cough, and other "pectoral diseases," and was also thought to be effective in preventing thirst.
Traditional Chinese Medicine (TCM)
Licorice appears in approximately 60% of traditional Chinese medicine prescriptions as an effective agent in the treatment of asthma, fatigue, dry cough, bronchitis, excessive phlegm, and for relieving drug toxicity. In traditional Chinese medicine, "nine out of ten formulae contain licorice"; it is considered one of the essential herbal medications. In Chinese traditional medicine, licorice (Gan Cao) remains one of the oldest and most commonly prescribed herbs and has been used in the treatment of numerous ailments ranging from tuberculosis to peptic ulcers.
General Traditional Indications Across Cultures
Licorice has held claim for therapeutic use for fevers, liver ailments, dyspepsia, gastric ulcers, sore throats, asthma, bronchitis, Addison's disease, and rheumatoid arthritis, and has been used as a laxative, antitussive, and expectorant. Licorice root has traditionally been used in herbal medicine to treat gastrointestinal problems such as gastritis and peptic ulcers. It is still commonly recommended for respiratory infections, coughs, and bronchitis. Additionally, it is applied topically to manage skin conditions like eczema and psoriasis, as well as enhance wound healing.
Traditional preparations included whole root decoctions, powders, and syrups. The German Commission E approves the use of licorice for catarrhal conditions of the upper respiratory tract, and the EMA recommends licorice as an expectorant for cough associated with the common cold.
3. Key Chemical Constituents and Active Compounds
Glycyrrhizin / Glycyrrhizic Acid
The main constituent of the roots is glycyrrhizin, a triterpenoid saponin that is almost 50 times sweeter than sucrose and is the primary active ingredient. Glycyrrhizin represents about 10% of the licorice root dry weight, being a mixture of potassium, calcium, and magnesium salts of glycyrrhizic acid that varies between 2% and 25%. Chemically, glycyrrhizin consists of one molecule of 18β-glycyrrhetinic acid and two molecules of glucuronic acid.
After oral administration, glycyrrhizin is metabolized to 18-glycyrrhetic acid 3-monoglucuronide and glycyrrhetic acid by intestinal bacteria. The main active constituent of licorice is the prodrug glycyrrhizin, which is successively converted to 3β-monoglucuronyl-18β-glycyrrhetinic acid (3MGA) and 18β-glycyrrhetinic acid (GA) in the intestines.
Flavonoids and Other Polyphenols
Beyond glycyrrhizin, licorice root contains flavonoids (approximately 1%), mainly the flavanones liquiritin and liquiritigenin, chalcones isoliquiritin, isoliquiritigenin, and isoflavonoids (formononetin); amines (1–2%) including asparagine, betaine, and choline; amino acids; 3–15% glucose and sucrose; starch (2–30%); polysaccharides; sterols; coumarins; resin; and volatile oils (0.047%). The yellow color of licorice is due to its flavonoid content.
Identified licorice components span several natural product classes, including chalcones (licochalcone A, isoliquiritigenin, isoliquiritin), flavanones (liquiritin, liquiritigenin), saponins (glycyrrhizin, glycyrrhetinic acid), and isoflavonoids, as well as glabridin, glycycoumarin, licoricidin, and p-hydroxybenzylmalonic acid.
Licorice consists of up to 300 active compounds.
4. Mechanisms of Action
Inhibition of 11β-Hydroxysteroid Dehydrogenase (11β-HSD2)
The most extensively characterized mechanism of licorice is the inhibition of the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). This enzyme is a NAD-dependent dehydrogenase mainly expressed in the kidney, intestine, salivary, and sweat glands. It can be inhibited by glycyrrhetinic acid, leading to functional mineralocorticoid excess due to unmetabolized cortisol at the level of classical target tissues of aldosterone.
Cortisol is normally decomposed by 11β-HSD2 in renal tubule cell cytoplasm into cortisone, which has a lower affinity for the mineralocorticoid receptor. Inhibition of 11β-HSD2 by glycyrrhizin metabolites results in a higher concentration of cortisol that binds to and stimulates the mineralocorticoid receptor.
Biochemical studies indicate that glycyrrhizinates inhibit 11β-hydroxysteroid dehydrogenase (type 2), the enzyme responsible for inactivating cortisol through conversion to cortisone. As a result, continuous high-level exposure to glycyrrhizin compounds can produce hypermineralocorticoid-like effects in animals and humans. These effects are reversible upon withdrawal of licorice or glycyrrhizin.
Anti-Inflammatory Mechanisms
Glycyrrhizin has anti-inflammatory effects not only by reducing plasma aldosterone but also by direct antagonistic effects at toll-like receptor 4 (TLR4), which is a crucial trigger for innate immunity. Glycyrrhetic acid is a potent inhibitor of 11β-hydroxysteroid dehydrogenase (11β-HSD) and performs a range of corticosteroid-like activities.
Estrogenic Activity
Other therapeutic uses of licorice are linked to its anti-androgen and estrogen-like activity, especially in the treatment of polycystic ovary syndrome (PCOS) in conjunction with spironolactone therapy. The flavanone liquiritigenin, found in licorice root, has been characterized in molecular studies as a selective estrogen receptor β agonist, which is proposed as a mechanism underlying licorice's phytoestrogenic effects at the cellular level.
Antiviral Mechanisms
There are reports indicating antiviral activity of glycyrrhizin and glycyrrhizic acid, where the compounds inhibited growth and cytopathology of hepatitis A and C, and immunodeficiency virus (HIV). The precise antiviral mechanism remains under investigation.
5. Scientific Evidence by Area of Use
5.1 Gastrointestinal Health: Peptic Ulcer and H. pylori
As a result of licorice's extensive folk use for gastric irritation, multiple studies in the 1970s and 1980s explored the efficacy of licorice, glycyrrhizinated compounds, deglycyrrhizinated licorice, and carbenoxolone in gastric/peptic ulcers. These studies largely showed inconclusive results and efficacy lower than other pharmaceutical agents such as cimetidine.
More recent clinical research has focused on licorice as an adjunct to H. pylori eradication therapy. A randomized controlled study conducted in 120 Helicobacter pylori-positive patients observed a significant increase in negative seroconversions among those who received supplemental licorice (380 mg twice daily for 2 weeks) as an adjunct to H. pylori triple therapy (83%) compared to triple therapy alone (62.5%; P=0.018). This response rate was significant only in patients with peptic ulcer disease and not in those with non-ulcer dyspepsia.
A separate controlled study examined H. pylori-infected peptic ulcer patients divided into groups receiving licorice alongside standard therapy versus standard therapy alone. Healing of peptic ulcer was visible in 95% of the licorice group and 70% of the control group. The eradicative effect of licorice against H. pylori was 70% in the licorice group compared to 45% in the control group. These figures based on urease breath test results were 55% and 40% respectively.
Regarding deglycyrrhizinated licorice (DGL) specifically: a retrospective trial on the efficacy of deglycyrrhizinated licorice studied the effect of 760 mg DGL extract administered five times daily for 24 weeks to 36 patients with histories of chronic gastric ulcers. Healing of the ulceration was observed in all patients, and in the majority the mucosa appeared normal. No side effects of the treatment were reported by the authors. The overall evidence base for DGL and gastric ulcers is considered preliminary, with small sample sizes and methodological limitations. Evidence indicates that licorice in combination with other herbs provides relief from the symptoms of functional dyspepsia and irritable bowel syndrome; however, clinical trials of both licorice alone and in combination are limited, and further evaluation is required.
5.2 Respiratory Conditions: Cough and Sore Throat
People most often take licorice to suppress coughs, to soothe a sore throat, and to relieve stomach upset. Regulatory-level assessments support traditional use in the respiratory tract: the German Commission E approves the use of licorice for catarrhal conditions of the upper respiratory tract, and the EMA recommends licorice as an expectorant for cough associated with the common cold.
Clinical evidence for its use perioperatively was assessed in a meta-analysis: a meta-analysis of 5 randomized trials (609 patients) reported that topical licorice applied prior to endotracheal intubation prevented postoperative sore throats by 56% and cough by 39%. This evidence, while promising, is specific to a perioperative context. For general cough suppression and expectorant use, the evidence base relies primarily on traditional use and limited clinical data.
5.3 Liver Disease: Viral Hepatitis
Licorice and glycyrrhizate compounds have long been used in the treatment of chronic viral hepatitis in China and Japan, but the possible mechanism of anti-viral activity remains unknown.
Several human studies have investigated the effect of glycyrrhizin on chronic HCV infection, with outcomes exhibiting that glycyrrhizin is adequate to protect and treat chronic hepatitis C patients. A clinical trial examined the effect of glycyrrhizin on European patients with hepatitis C virus (HCV)-RNA. Fifty-seven chronic hepatitis C patients were randomly assigned to one of four dosage groups: 80, 160, or 240 mg glycyrrhizin, or placebo. The 240 mg dose of glycyrrhizin given three times weekly did not affect HCV-RNA levels but did lower serum ALT during treatment, and was well tolerated and safe.
There are not enough data to determine whether licorice is effective for complications caused by hepatitis C. The available human evidence for intravenous glycyrrhizin in hepatitis is more developed than for oral preparations, and the overall evidence quality remains moderate; large, definitive randomized controlled trials are lacking.
5.4 Oral Health: Aphthous Ulcers (Canker Sores) and Antimicrobial Effects
Licorice mouth rinse or gargle might reduce ulcer size and pain in people with recurrent canker sores, while topical licorice might reduce ulcer size only. In one study, using a licorice extract in combination with a medicine to treat canker sores was more effective than using the medicine alone.
Recently, the use of licorice in the treatment and management of oral diseases has been recognized. Some research suggests that licorice extract may help kill bacteria in the mouth that cause tooth decay. Evidence for oral health uses comes primarily from small trials and in vitro studies; the strength of evidence is considered preliminary and not yet sufficient to draw definitive conclusions.
5.5 Menopausal Symptoms
Several small clinical trials have evaluated licorice for hot flashes. A double-blind controlled clinical trial examined the effects of licorice root on hot flashes in menopausal women. Ninety menopausal women were randomly divided into two groups: one receiving 3 capsules daily containing 330 mg licorice extract and the other receiving 3 capsules daily containing 330 mg starch (placebo) over 8 weeks of intervention and 4 weeks of follow-up. Data within and between the groups were analyzed by ANOVA with repeated measurements and t-test. The trial found effects on frequency and severity of hot flashes, but the sample size was small and the study had methodological limitations. Evidence in this area is preliminary and requires confirmation in larger, well-powered trials.
5.6 Polycystic Ovary Syndrome (PCOS)
Women with polycystic ovary syndrome (PCOS) are more likely to suffer from anovulatory infertility. Studies have shown the effectiveness of licorice on the regulation of sex hormones and quality of life, with inconsistent findings. A randomized double-blind controlled trial included 66 overweight or obese women with PCOS; participants were randomly divided into two groups, one receiving 1.5 g/day of licorice extract alongside a low-calorie diet and the other receiving placebo plus a low-calorie diet for 8 weeks. Other therapeutic uses of licorice are linked to its anti-androgen and estrogen-like activity, especially in PCOS in conjunction with spironolactone therapy. Evidence in this area consists of small trials with heterogeneous populations and inconsistent results; it remains preliminary.
5.7 Depression and Mental Health
A pilot study examined the adjunct use of Glycyrrhiza glabra in depression via its 11β-HSD2 inhibition mechanism. A demonstrated molecular mechanism is the inhibition of 11β-HSD2 in the periphery. This inhibition allows cortisol to reach the intracellular mineralocorticoid receptor, which is otherwise metabolized by the enzyme. The clinical evidence in this domain consists of a single small pilot study (Frontiers in Psychiatry, 2020) and is too preliminary to support conclusions about efficacy.
5.8 Inflammation and Immune Modulation
Many important research projects have established several beneficial effects for licorice as a medicinal herb, including anti-inflammatory, antimicrobial, antiviral, antiprotozoal, antioxidant, antihyperglycemic, antihyperlipidemic, hepatoprotective, and neuroprotective properties. Most of this evidence comes from preclinical (animal and cell culture) studies; human clinical evidence for purely anti-inflammatory indications is limited. Some studies of licorice in people have been completed, but there is not enough high-quality evidence to clearly support its use for any health condition.
6. Body Systems and Health Areas Associated with Licorice Root
Based on the literature, licorice root has been associated with the following body systems and health areas:
- Gastrointestinal system: Licorice root has a wide range of pharmacological effects, including multiple pharmacological effects on the digestive system. Traditional and modern use encompasses gastritis, peptic ulcer, dyspepsia, and irritable bowel syndrome.
- Respiratory system: Cough suppression, expectorant action, sore throat, bronchitis, and asthma, supported by both traditional use and regulatory endorsements from the German Commission E and EMA.
- Hepatic (liver) system: Glycyrrhizin is the major active constituent obtained from licorice roots and is one of the most widely used in herbal preparations for the treatment of liver complaints.
- Endocrine and adrenal system: Licorice root has adrenocortical hormone-like effects. The inhibition of 11β-HSD2 influences cortisol metabolism, with implications for adrenal support and hormonal regulation.
- Reproductive and hormonal system: Phytoestrogenic and anti-androgenic activities have been studied in the context of PCOS, menopause, and sex hormone regulation.
- Cardiovascular system: Licorice root has multiple pharmacological effects on the cardiovascular system. Both therapeutic implications and safety concerns (hypertension, hypokalemia) are relevant to this system.
- Immune system: Antiviral activity has been studied against hepatitis viruses and HIV, primarily at the preclinical level with some clinical data for hepatitis C.
- Oral cavity: Antimicrobial activity against dental pathogens and use for aphthous ulcers (canker sores) have been studied clinically.
- Skin: Cosmetic products utilize licorice root extract due to its anti-inflammatory and skin-soothing properties. Topical licorice has been studied for eczema and psoriasis.
7. Dosage Forms and Dosages Reported in Studies
Dosages vary considerably by indication, preparation type, and glycyrrhizin content. The following are dosages as reported in specific sources:
- Licorice root has been used in daily doses from 760 mg to 15 g for ulcer, gastritis, and non-alcoholic fatty liver disease.
- For licorice tincture (1:5 strength), the dose is 2 to 5 mL three times a day.
- A standardized licorice extract dose of 250 to 300 mg three times a day (containing 20% glycyrrhizic acid) has been reported for asthma.
- In the case of gastroesophageal reflux disease, two 380 mg tablets of deglycyrrhizinated licorice (DGL) taken before meals has been described.
- For supportive treatment of ulcer pain alongside conventional medical care, the standard dose reported is two to four 380 mg tablets of DGL with meals and at bedtime.
- In the H. pylori RCT (120 patients), supplemental licorice was given at 380 mg twice daily for 2 weeks as an adjunct to triple therapy.
- In the menopausal hot flash trial (n = 90), the licorice group received 3 capsules daily containing 330 mg licorice extract for 8 weeks.
- In a hepatitis C clinical trial, 57 patients were assigned to groups receiving 80, 160, or 240 mg glycyrrhizin or placebo; the 240 mg dose given three times weekly was the highest dose tested.
- In a PCOS randomized double-blind trial (n = 66), participants received 1.5 g/day of licorice extract alongside a low-calorie diet for 8 weeks.
- A typical dose of whole licorice is reported as 5 to 15 grams daily; however, experts recommend against using this high dose for more than a few weeks.
8. Safety Considerations and Drug Interactions
Pseudoaldosteronism and the Glycyrrhizin Toxicity Syndrome
The primary and most clinically significant safety concern with licorice root is the syndrome of pseudoaldosteronism (also called pseudohyperaldosteronism) caused by glycyrrhizin and its metabolites. Hypokalemia or pseudoaldosteronism (PsA) is one of the most frequent side effects of licorice intake. Glycyrrhizin metabolites inhibit type 2 11β-hydroxysteroid dehydrogenase, which decomposes cortisol into inactive cortisone in the distal nephron, thereby inducing mineralocorticoid receptor activity.
The clinical presentation of PsA is similar to that of primary aldosteronism and is characterized by peripheral edema, hypertension, laboratory hypokalemia, and lower plasma renin activity, due to the excessive action of mineralocorticoid receptors. Chronic consumption leads to the development of hypertension, metabolic alkalosis, and hypokalemia.
Severe, and sometimes fatal, complications following ingestion of licorice can occur. In these cases, significant quantities of licorice have typically been consumed in the short- to medium-term. Reported complications include rhabdomyolysis, hypertensive encephalopathy, and cardiac arrest and death. In one case, long-term licorice use led to pseudoaldosteronism with intractable hypokalemia, the result being lethal polymorphic ventricular arrhythmias.
High dosage and long-term use of licorice are constitutional risk factors for PsA. Orally administered glycyrrhizin is effectively hydrolyzed to glycyrrhetinic acid by intestinal bacteria in constipated patients, which enhances the bioavailability of glycyrrhizin metabolites.
In most cases, hypertension and hypervolemia induced by licorice are reversible once intake is stopped.
Regulatory Status
Licorice and its derivatives are recognized as safe by the US Food and Drug Administration (FDA) as a food additive in certain concentrations; however, the FDA has issued warnings against its use in at-risk groups and in larger amounts.
Pregnancy
Consuming oral licorice extract in large amounts (about 250 grams of licorice per week) during pregnancy is unsafe and can increase the risk of delivery before a gestational age of 38 weeks. Licorice may have steroidal and estrogenic effects in pregnancy and may increase the risk of preterm delivery. High licorice consumption during pregnancy may stimulate hypothalamic-pituitary-adrenocortical axis function in the child; therefore, pregnant women should avoid licorice. Little is known about whether it is safe to use licorice while breastfeeding.
Drug Interactions
Caution is advised with antihypertensive drugs, warfarin, estrogen, paclitaxel, and cisplatin, as licorice may reduce their effectiveness. Concomitant use with corticosteroids may potentiate potassium depletion and increase levels and duration of activity of corticosteroids.
Digoxin: Licorice should be used with caution with digoxin (Lanoxin) because licorice can lower potassium levels in the body, and low potassium can lead to increased digoxin side effects including dizziness, headache, nausea, diarrhea, irregular heart rate and rhythm, and visual disturbances.
Warfarin: Licorice should not be used with warfarin (Coumadin) because it can accelerate the breakdown of warfarin and decrease its effectiveness, leading to an increased risk of clotting.
Antihypertensives: Licorice may decrease the effectiveness of antihypertensive (blood pressure–lowering) medications due to an increase in salt and water retention.
Diuretics: Licorice overuse may increase cardiac toxicity with digoxin and potentiate potassium loss with non-potassium-sparing diuretics.
Corticosteroids: Corticosteroid anti-inflammatory drugs have similar side effects to licorice. When licorice is taken together with corticosteroids, the likelihood of experiencing these side effects increases significantly.
Hormonal medications: Licorice should be used with caution in women taking birth control pills or other hormonal medications. Licorice may change hormone levels in the body and decrease the effectiveness of estrogen-containing medications.
Cytochrome P450 enzymes: Animal and in vitro studies have found licorice to inhibit CYP2B6, CYP2C19, and CYP2C8, induce CYP3A4, and produce inhibitory and inducing effects on CYP2C9 isoenzymes. These findings suggest the potential for broad interactions with drugs metabolized by these enzymes, though clinical confirmation in humans is limited.
MAO inhibitors: Some experts believe that licorice has some activity similar to a class of antidepressants called monoamine oxidase (MAO) inhibitors and thus may intensify adverse effects of these medications.
Perioperative use: Licorice should be stopped 2 weeks before surgery to minimize effects on blood pressure.
Potassium-sparing agents: Conversely, potassium-sparing medications such as aldosterone blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers prevent licorice-induced hypokalemia.
DGL as a Safer Alternative
DGL preserves licorice's beneficial flavonoids (glabridin, liquiritigenin, isoliquiritigenin) and polysaccharides while removing the glycyrrhizin component. These retained compounds provide anti-inflammatory, antioxidant, and mucosal-protective effects that support gastrointestinal health. Because the mineralocorticoid-active glycyrrhizin has been removed, DGL does not carry the same risk of hypertension and hypokalemia as whole licorice preparations.
References
- National Center for Complementary and Integrative Health (NCCIH) – Licorice Root: Usefulness and Safety
- PMC – Liquorice (Glycyrrhiza glabra): A Phytochemical and Pharmacological Review
- PMC – Phytochemical Constituents and Pharmacological Effects of Licorice: A Review
- Food Frontiers (Wiley) – A Review on Phytochemicals, Pharmacological Activities, Drug Interactions, and Associated Toxicities of Licorice
- PMC – The Anti-Inflammatory Activity of Licorice, a Widely Used Chinese Herb
- PMC – Bioactive Candy: Effects of Licorice on the Cardiovascular System
- Frontiers in Endocrinology – Licorice: From Pseudohyperaldosteronism to Therapeutic Uses
- Frontiers in Nutrition – Clinical Risk Factors of Licorice-Induced Pseudoaldosteronism Based on Glycyrrhizin-Metabolite Concentrations
- PMC (Cureus) – How Much Is Too Much? Exploring Pseudohyperaldosteronism in Glycyrrhizic Acid Toxicity from Chronic Licorice Root Consumption
- PMC – The Healing Effect of Licorice (Glycyrrhiza glabra) on Helicobacter pylori Infected Peptic Ulcers
- Plants (MDPI) – Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology
- PMC – Effects of Licorice on Relief and Recurrence of Menopausal Hot Flashes
- PMC – Licorice Root Components in Dietary Supplements are Selective Estrogen Receptor Modulators with a Spectrum of Estrogenic and Anti-Estrogenic Activities
- PMC – Efficacy of Licorice Extract in Combination with a Low-Calorie Diet on Sex Hormones, Sleep Quality, Depression, and Appetite in Overweight/Obese Women with PCOS: An RCT
- Merck Manual Professional Edition – Licorice
- ScienceDirect – Risk and Safety Assessment on the Consumption of Licorice Root (Glycyrrhiza sp.): Emphasis on Glycyrrhizin Pharmacology and Toxicology
- PMC – Clinical Risk Factors of Licorice-Induced Pseudoaldosteronism (Narrative Review)
- Frontiers in Psychiatry – Adjunct Therapy With Glycyrrhiza Glabra Rapidly Improves Outcome in Depression
- Journal of Medicinal Food – A Review of the Pharmacological Efficacy and Safety of Licorice Root from Corroborative Clinical Trial Findings
- PMC – Identification and Chemical Standardization of Licorice Raw Materials and Dietary Supplements Using UHPLC-MS/MS
- PMC – The Power of Licorice (Radix glycyrrhizae) to Improve Oral Health: A Comprehensive Review
- Medscape – Licorice Poisoning: Background, Pathophysiology, Prognosis
- Journal of Primary Health Care – Liquorice
- European Medicines Agency (EMA) – Assessment Report on Glycyrrhiza glabra and Related Species
- ScienceDirect – Licorice: Resources, Applications in Ancient and Modern Times
- Phytotherapy Research (Wiley) – The Genus Glycyrrhiza (Fabaceae Family) and Its Active Constituents as Protective Agents Against Natural or Chemical Toxicities